Abstract:Protein–protein interactions (PPIs) execute many fundamental cellular functions and have served as prime drug targets over the last two decades. Interfering intracellular PPIs with small molecules has been extremely difficult for larger or flat binding sites, as antibodies cannot cross the cell membrane to reach such target sites. In recent years, peptides smaller size and balance of conformational rigidity and flexibility have made them promising candidates for targeting challenging binding interfaces with satisfactory binding affinity and specificity. Deciphering and characterizing peptide–protein recognition mechanisms is thus central for the invention of peptide-based strategies to interfere with endogenous protein interactions, or improvement of the binding affinity and specificity of existing approaches. Importantly, a variety of computation-aided rational designs for peptide therapeutics have been developed, which aim to deliver comprehensive docking for peptide–protein interaction interfaces. Over 60 peptides have been approved and administrated globally in clinics. Despite this, advances in various docking models are only on the merge of making their contribution to peptide drug development. In this review, we provide (i) a holistic overview of peptide drug development and the fundamental technologies utilized to date, and (ii) an updated review on key developments of computational modeling of peptide–protein interactions (PepPIs) with an aim to assist experimental biologists exploit suitable docking methods to advance peptide interfering strategies against PPIs.

The application progress of peptides in drug delivery systems in the past decade

Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules

Peptides in Target Delivery of Drugs and Treatment of Diseases: Research Progress

Recent Advances in Peptides for Enhancing Transdermal Macromolecular Drug Delivery.

Penetrating peptides: Applications in drug delivery

Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress

Recent Progress of Cell-Penetrating Peptides As New Carriers for Intracellular Cargo Delivery.

Therapeutic peptides: current applications and future directions

Transporting Carriers for Intracellular Targeting Delivery Via Non-Endocytic Uptake Pathways

Peptide-Mediated Nanocarriers for Targeted Drug Delivery: Developments and Strategies

Peptide-based non-viral gene delivery: A comprehensive review of the advances and challenges

Cell-penetrating peptides: tools for intracellular delivery of therapeutics

[Advances in the research and application of cell penetrating peptides]

Progress in tumour-targeted drug delivery based on cell-penetrating peptides

Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides

Peptide-Enabled Targeted Delivery Systems for Therapeutic Applications

Peptide-based supramolecular hydrogels and their biotherapeutic applications

Polypeptide-Based Systems: From Synthesis to Application in Drug Delivery

Peptide-Based Supramolecular Hydrogels as Drug Delivery Agents: Recent Advances

Engineering peptide drug therapeutics through chemical conjugation and implication in clinics

A Comprehensive Review on Current Advances in Peptide Drug Development and Design